Revolution Medicines (RVMD) operating margin

Operating margin · fiscal 2023
-4207.1%

Revolution Medicines (RVMD) had an operating margin of -4207.1% in fiscal 2023 (the year ended December 31, 2023). That is 3477.1 percentage points lower than the -730.0% of fiscal 2022. Figures as of 17 Nov 2026, 21:40 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2023
-4207.1%
Change on fiscal 2022
−3477.1 pts
Highest on record
-108.2%fiscal 2019
Lowest on record
-4207.1%fiscal 2023
Fiscal years on record
62018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Revolution Medicines operating margin, in more detail

Across the 6 fiscal years on record (2018–2023), the highest was -108.2% in fiscal 2019 and the lowest -4207.1% in fiscal 2023. The fiscal 2023 figure is no higher than in any of the 5 earlier fiscal years on record, whose median is -257.5%.

Net margin was -3768.3% in fiscal 2023.

History · 6 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Revolution Medicines operating margin, year by year

Revolution Medicines (RVMD) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2023-4207.1% 3477.1 pts down-3768.3%
2022-730.0% 90.3 pts down-703.0%
2021-639.7% 382.2 pts down-636.6%
2020-257.5% 149.4 pts down-251.6%
2019-108.2% 91.8 pts up-95.2%
2018-200.0%—-207.2%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Revolution Medicines and comparable companies
CompanyOperating marginFiscal year
BeOne Medicines ONC8.4%2025
Waters WAT25.4%2025
Natera NTRA-13.4%2025
IQVIA Holdings IQV14.0%2025
Revolution Medicines RVMD-4207.1%2023
Royalty Pharma RPRX65.6%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines operating margin: questions and answers

What is Revolution Medicines's operating margin?

Revolution Medicines (RVMD) had an operating margin of -4207.1% in fiscal 2023 (the year ended December 31, 2023). That is 3477.1 percentage points lower than the -730.0% of fiscal 2022.

Is Revolution Medicines's operating margin high or low compared with its own history?

The fiscal 2023 figure is no higher than in any of the 5 earlier fiscal years on record, whose median is -257.5%.

What are the highest and lowest operating margin figures on record for Revolution Medicines?

Across the 6 fiscal years on record (2018–2023), the highest was -108.2% in fiscal 2019 and the lowest -4207.1% in fiscal 2023.

What are Revolution Medicines's gross and net margins?

Net margin was -3768.3% in fiscal 2023.

How is Revolution Medicines's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/RVMD/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.